D-0605-2017 Class II Terminated

Recalled by Zydus Pharmaceuticals USA Inc — Pennington, NJ

FDA drug recall D-0605-2017 was initiated by Zydus Pharmaceuticals USA Inc on Mar 6, 2017 and is designated Class II. Reason for recall: Presence of Foreign Tablets/Capsules: Customer complaint that a bottle of atenolol 50 mg Tablets USP contained a paroxetine 20 mg tablet. The recall status is terminated (terminated Nov 5, 2019). Affected quantity: 9561 bottles.

Recall details

Product Type
Drugs
Report Date
Mar 29, 2017
Initiation Date
Mar 6, 2017
Termination Date
Nov 5, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
9561 bottles

Product description

ATENOLOL Tablets, USP, 50 mg, packaged in a) 100-count bottles (NDC 68382-023-01) and b) 1000-count bottles (NDC 68382-023-10), Rx only, Manufactured by: Cadila Healthcare Ltd., India; Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534.

Reason for recall

Presence of Foreign Tablets/Capsules: Customer complaint that a bottle of atenolol 50 mg Tablets USP contained a paroxetine 20 mg tablet.

Distribution pattern

Nationwide in the USA and Puerto Rico.

Code information

Lot #: a) Z600724, Exp 04/18; Z600725, Exp 04/18

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0605-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0605-2017. Report a data issue: hello@regdatalab.com.